April 23, 2018Open Access
Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
R
Richard W. Joseph
Daiichi Sankyo (United States)
J
Jeroen Elassaiss‐Schaap
Utrecht University
Richard Kefford
Université Paris-Sud
Journals
Clinical Cancer Research
Actions
Institutions
University of Pennsylvania
University of California, Los Angeles
University of California, San Francisco
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...